-
Loading metrics
Open Access
Peer-reviewed
Research Article
Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial
-
Matthew B. Laurens,
Affiliation Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
⨯ -
Mahamadou A. Thera,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Drissa Coulibaly,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Amed Ouattara,
Affiliations Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America, Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Abdoulaye K. Kone,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Ando B. Guindo,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Karim Traore,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Idrissa Traore,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Bourema Kouriba,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Dapa A. Diallo,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Issa Diarra,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Modibo Daou,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Amagana Dolo,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Youssouf Tolo,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Mahamadou S. Sissoko,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Amadou Niangaly,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Mady Sissoko,
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ -
Shannon Takala-Harrison,
Affiliation Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
⨯ -
Kirsten E. Lyke,
Affiliation Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
⨯ -
Yukun Wu,
Affiliation Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
⨯ -
William C. Blackwelder,
Affiliation Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
⨯ -
Olivier Godeaux,
Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium
⨯ -
Johan Vekemans,
Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium
⨯ -
Marie-Claude Dubois,
Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium
⨯ -
W. Ripley Ballou,
Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium
⨯ -
Joe Cohen,
Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium
⨯ -
Tina Dube,
Affiliation EMMES Corporation, Rockville, Maryland, United States of America
⨯ -
Lorraine Soisson,
Affiliation Malaria Vaccine Development Program, U.S. Agency for International Development, Washington, DC, United States of America
⨯ -
Carter L. Diggs,
Affiliation Malaria Vaccine Development Program, U.S. Agency for International Development, Washington, DC, United States of America
⨯ -
Brent House,
Affiliation U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Jason W. Bennett,
Affiliation U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
David E. Lanar,
Affiliation U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Sheetij Dutta,
Affiliation U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
D. Gray Heppner,
Affiliation U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
⨯ -
Christopher V. Plowe ,
* E-mail: cplowe@medicine.umaryland.edu
Affiliation Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
⨯ - [ ... ],
-
Ogobara K. Doumbo
Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali
⨯ - [ view all ]
- [ view less ]
Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial
- Matthew B. Laurens,
- Mahamadou A. Thera,
- Drissa Coulibaly,
- Amed Ouattara,
- Abdoulaye K. Kone,
- Ando B. Guindo,
- Karim Traore,
- Idrissa Traore,
- Bourema Kouriba,
- Dapa A. Diallo
- Published: November 18, 2013
- https://doi.org/10.1371/journal.pone.0079323